# 18_COMMERCIALIZATION.md — Commercialization Recommendation Engine

> **MODULE NUMBERING CONTEXT:**  
> Consistent across Official Specification and Mentor Communications: **Module 8: Commercialization Recommendation Module**.

---

## 1. Commercialization Dimensions & Evaluation

The Commercialization Recommendation Engine evaluates scientific research and patent portfolios across **four core readiness dimensions**:

| Dimension | Target Focus | Evaluation Metrics | Scoring Range |
| :--- | :--- | :--- | :---: |
| **1. IP Defensibility** | Intellectual property moat and freedom-to-operate | Granted patent count, forward citation density, multi-domain breadth, lack of litigation flags | 0 – 100 |
| **2. Market Demand** | Commercial appetite and industry growth | Multi-year technology CAGR, market size estimates, venture capital interest | 0 – 100 |
| **3. Regulatory Feasibility** | Compliance and approval hurdles | Domain classification (Software vs Medical Device vs Therapeutics vs Clean Energy) | 0 – 100 |
| **4. Team / Execution Capability** | Investigator experience and institutional support | Prior project completions, academic history, patent track record, lab seniority | 0 – 100 |

---

## 2. Strategic Commercialization Pathways

Based on the composite readiness score and TRL estimation, the engine automatically recommends one of three primary strategic pathways:

### Pathway 1: `LICENSING` (Corporate IP Monetization)
- **Trigger Conditions:** High IP Defensibility (>65) + Low/Moderate Team Capability (<50) or Low Founder Readiness.
- **Strategic Recommendation:** Out-license intellectual property to established enterprise market leaders in exchange for upfront licensing fees and running royalties.
- **Best Suited For:** Academic researchers wishing to remain in academia while monetizing laboratory discoveries.

### Pathway 2: `SPINOUT_VENTURE` (New Startup Formation)
- **Trigger Conditions:** High Market Demand (>70) + High Team Capability (>65) + High IP Defensibility (>60) + TRL >= 4.
- **Strategic Recommendation:** Incorporate an independent spinout startup, apply for SBIR/STTR non-dilutive phase I/II grants, and seek seed venture capital.
- **Best Suited For:** Postdocs, PhD graduates, and serial entrepreneurs ready to commercialize deep tech.

### Pathway 3: `JOINT_DEVELOPMENT` (Industry-Academic Consortium)
- **Trigger Conditions:** Moderate TRL (3–5) + High Regulatory Complexity + Moderate IP Defensibility.
- **Strategic Recommendation:** Form a public-private partnership or sponsored research agreement with corporate R&D divisions to co-develop prototype validation.
- **Best Suited For:** Complex industrial hardware, clean tech infrastructure, and clinical biotech.

---

## 3. Implementation Codebase Details

- **REST Endpoints (`backend/app/api/v1/endpoints/commercialization.py`):**
  - `GET /api/v1/commercialization/summary`: Overview of commercial readiness and pathway distribution.
  - `GET /api/v1/commercialization/readiness`: Granular scores for the 4 readiness dimensions.
  - `GET /api/v1/commercialization/recommendations`: Top recommended strategic pathway with actionable rationale.
  - `GET /api/v1/commercialization/evidence`: Complete supporting data points and phased execution roadmap.
- **Service Class:** `CommercializationService` in `backend/app/services/commercialization_service.py`.
- **Frontend View:** `/commercialization` in `frontend/src/app/(dashboard)/commercialization/page.tsx` (Dimension score cards, pathway badge, interactive phased milestone roadmap).
- **Automated Tests:** `backend/tests/test_commercialization.py` (8 passing tests).
- **Status:** 🟢 **IMPLEMENTED (RULE-BASED HEURISTIC)**
